Core Viewpoint - Xcelerate, Inc. has divested its majority interest in the ESN Group of companies to Noble Labs Holdings, LLC in an all-cash transaction to refocus on its core mission of implementing AI-aided medical technology and virtual healthcare in Africa through its subsidiary AfiyaSasa Africa, LLC [1] Company Summary - The sale includes the ESN Group, Inc. and California Skin Research, Inc. [1] - Noble Labs Holdings, LLC had previously provided funding and marketing support to the ESN Group, indicating a strategic partnership [1] - The decision to divest was made to realign the company's focus on its original mission [1]